Advertisement
Screener

NUTRIBAND INC. (NTRB) Business Acquisition, Pro Forma Revenue

2.9 / 5 stars · 32/55 Roast Me

NUTRIBAND INC. Business Acquisition, Pro Forma Revenue

NUTRIBAND INC. (NTRB) reported Business Acquisition, Pro Forma Revenue of $1.37 million for the 12-month period ending 2022-01-31, per its 10-K filed 2022-04-29.

Discontinued › Income Statement › Other Income

us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2022-04-29

  • NUTRIBAND INC. business acquisition, pro forma revenue for the quarter ending 2021-07-31 was $326.68K.
  • NUTRIBAND INC. business acquisition, pro forma revenue for the quarter ending 2021-04-30 was $303.19K.
  • NUTRIBAND INC. business acquisition, pro forma revenue for the quarter ending 2021-01-31 was -$797.45K.
  • NUTRIBAND INC. business acquisition, pro forma revenue for the quarter ending 2020-01-31 was -$368.65K, a 547.01% decline year-over-year.
  • NUTRIBAND INC. business acquisition, pro forma revenue for fiscal 2022 was $1.37M, a 0.00% change from fiscal 2021.
  • NUTRIBAND INC. business acquisition, pro forma revenue for fiscal 2021 was $1.37M, a 31.29% decline from fiscal 2020.
  • NUTRIBAND INC. business acquisition, pro forma revenue for fiscal 2020 was $1.99M, a 245.40% increase from fiscal 2019.
  • NUTRIBAND INC. business acquisition, pro forma revenue for fiscal 2019 was $577.15K, a 1.61% increase from fiscal 2018.
Period endBusiness Acquisition, Pro Forma Revenue 3 monthBusiness Acquisition, Pro Forma Revenue 6 monthBusiness Acquisition, Pro Forma Revenue 9 monthBusiness Acquisition, Pro Forma Revenue 12 month
2022-01-31$1.37M
10-K · filed 2022-04-29
2021-07-31$326.68K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-09-03
$629.87K
10-Q · filed 2021-09-03
-$167.57K
derived: sum of 3 quarters · filed 2021-09-03
2021-04-30$303.19K
10-Q · filed 2021-06-14
-$494.26K
derived: sum of 2 quarters · filed 2021-06-14
2021-01-31-$797.45K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-02
$1.37M
10-K · filed 2021-04-02
2020-10-31$2.17M
10-Q · filed 2021-12-14
2020-01-31-$368.65K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-02
$1.99M
10-K · filed 2021-04-02
2019-10-31$2.36M
10-Q · filed 2020-12-15
2019-01-31$82.47K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-14
$245.28K
derived: sum of 2 quarters · filed 2020-04-14
$452.79K
derived: sum of 3 quarters · filed 2020-04-14
$577.15K
10-K · filed 2020-04-14
2018-10-31$162.81K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-12-12
$370.32K
derived: sum of 2 quarters · filed 2019-12-12
$494.68K
10-Q · filed 2019-12-12
2018-07-31$207.51K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-09-13
$331.86K
10-Q · filed 2019-09-13
2018-04-30$124.36K
10-Q · filed 2019-06-13
2018-01-31$568.00K
10-K · filed 2019-04-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
Conexeu Sciences Inc. (CNXU)United States$0.111B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
Inogen Inc (INGN)United States$0.139B-7.00
MYOMO, INC. (MYO)United States$0.065B-2.85
Envoy Medical, Inc. (COCH)United States$0.056B
ALPHA PRO TECH LTD (APT)$0.052B13.63
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
Lifeward Ltd. (LFWD)$0.021B
ENvue Medical, Inc. (FEED)United States$0.011B